Skip to main content

Premium Project

Delayed Investigations Impact Audit

Audit whether delayed investigations are identified, documented, escalated and acted on, and whether delays affect diagnosis, treatment, discharge, length of stay, patient safety or service flow.

PremiumNew
Explore Catalogue

Overview

This project audits the quality, timeliness, documentation and impact of investigations that were requested, awaited, delayed, not completed, not reported, not reviewed or not acted on within locally expected timescales. It reviews request quality, delay recognition, result review and action, escalation, ownership, handover, discharge planning and safety-netting, and shows where delay contributes to diagnostic delay, treatment delay, prolonged stay or avoidable clinical risk.

Specialties, services & categories

Clinical specialties:Acute MedicineEmergency MedicineGeneral Internal MedicineGeriatric MedicineFrailtySurgeryOrthopaedicsRespiratory MedicineCardiologyGastroenterologyNeurologyRenal MedicineOncology and HaematologyRadiology and Diagnostics
Healthcare services:Clinical GovernanceNursing & AHPsPharmacy
Categories:Patient Flow & Operational ImprovementPatient SafetyGovernance

Who should use it

  • Acute medicine, emergency medicine and general internal medicine teams
  • Radiology, endoscopy and pathology pathway leads and diagnostic service leads
  • Ward leaders, nurses, ACPs and physician associates
  • Discharge coordinators, site, patient-flow and clinical operations teams
  • QI leads, governance teams and educators

Objectives

  • Measure documentation of investigation indication, request details, urgency and expected timeframe
  • Identify delay points, delay categories and recognition of delay against locally configured timeframes
  • Assess result review, escalation of abnormal results, ownership, handover and safety-netting
  • Identify variation by clinical area / location, investigation type and delay category
  • Generate governance-ready and ARCP-ready evidence

Data collected

  • Anonymous case identifier
  • Inclusion / eligibility decision
  • Anonymised biodata (age band, recorded sex/gender, care setting, assessment context)
  • Investigation type, delay category and documented impact of delay
  • Clinical area / location and optional specialty / service
  • Fourteen delayed-investigation audit criteria (met / not met / not applicable)
  • Free-text learning points and any project custom fields

Outputs generated

  • Live dashboard
  • Audit report (Word)
  • Executive summary (Word)
  • Excel workbook
  • PowerPoint presentation
  • Conference poster
  • ARCP evidence summary

Standards and guidance

This ready-built project is developed using the guidance, standards and authoritative sources listed below, so you can see what is being measured and why. Lazomis QI does not publish or own this guidance, and inclusion here does not imply endorsement or approval by any of these organisations.

Governance notes

  • Designed to use anonymised or pseudonymised audit identifiers.
  • This tool supports, but does not replace, clinical judgement.
  • Local policy, formulary and specialist advice should be followed.
  • Organisations remain responsible for local governance arrangements.
  • This tool supports, but does not replace, clinical judgement. Follow local policy, diagnostic pathways and specialist advice.
  • Use anonymous case identifiers only — never patient-identifiable information.

Lazomis QI supporting resources